Image

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

Recruiting
18 years and older
Male
Phase N/A

Powered by AI

Overview

This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.

Description

This study aims to compare the effectiveness of low-field MRI (0.55T) with traditional high-field MRI (3T) in prostate cancer screening and image quality improvement. The study is conducted in three phases: first, a pilot study with healthy volunteers to optimize the low-field MRI protocol; second, an evaluation of image quality between the two types of MRI in patients with metallic artifacts, particularly due to hip prostheses; and finally, the assessment of low-field MRI in patients with suspicious prostate lesions on high-field MRI (3T).

The goal is to find an accessible solution for prostate cancer screening while maintaining or improving image quality.

Eligibility

Inclusion Criteria:

Work Package1 (WP): 0.55T MRI Protocol Development

  • Healthy male volunteers aged 18 and above.
  • Agree to be contacted for incidental findings
  • Signed informed consent

WP2: 0.55T Prostate MRI with patients with metallic implant(s)

  • Adult men (≥18 y.o) with 3T MRI reported as sub-diagnostic due to metallic implants
  • Signed informed Consent

WP3: 0.55T Prostate MRI with patients with suspicious lesion(s)

  • Adult men (≥18 y.o)
  • PI-RADS 4/5 lesions detected on 3T MRI, schedules for targeted biopsy
  • Signed informed consent

Exclusion Criteria:

WP1: 0.55T MRI Protocol Development

  • Individuals with a history of prostate cancer
  • MR Contraindications as listed in the MR Safety Screening form

WP2: 0.55T Prostate MRI with patients with metallic implant(s)

  • Contraindications as per MD instructions
  • Any condition making the patient unsuitable for the study
  • Refusal to be notified in case of incidental finding on the examination

WP3: 0.55T Prostate MRI with patients with suspicious lesion(s)

  • Individuals with a history of prostate cancer.
  • Contraindications as per MD instructions
  • Any condition making the patient unsuitable for the study
  • Refusal to be notified in case of incidental finding on the examination

Study details
    Prostate Cancer

NCT06482489

University of Lausanne Hospitals

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.